Independent analysis puts a ERP survodutide lot at 96.4%, against 93.7% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 23 of 48 of this archive, newest first.
The supplier has not disputed the finding. It has not explained the gap either.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The purity figure is the least informative line on a well-constructed certificate and the only line most buyers read.
Follow the resin, not the catalogue.
The result is unremarkable. What the report omits is not.
The route did not close because of a rule about peptides.
A reminder that a purity figure is the output of a method, and that methods differ.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The result is unremarkable. What the report omits is not.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.